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SMOKING AND HORMESIS AS CONFOUNDING FACTORS IN RADIATION
PULMONARY CARCINOGENESIS
Charles L. Sanders  Korea Advanced Institute of Science and Technology,
Department of Nuclear and Quantum Engineering, 373-1 Guseong-dong, Yuseong-
gu, Daejeon, Republic of Korea
Bobby R. Scott  Lovelace Respiratory Research Institute, 2425 Ridgecrest Drive
SE, Albuquerque, NM
 Confounding factors in radiation pulmonary carcinogenesis are passive and active cig-
arette smoke exposures and radiation hormesis. Significantly increased lung cancer risk
from ionizing radiation at lung doses < 1 Gy is not observed in never smokers exposed to
ionizing radiations. Residential radon is not a cause of lung cancer in never smokers and
may protect against lung cancer in smokers. The risk of lung cancer found in many epi-
demiological studies was less than the expected risk (hormetic effect) for nuclear weapons
and power plant workers, shipyard workers, fluoroscopy patients, and inhabitants of high-
dose background radiation. The protective effect was noted for low- and mixed high- and
low-linear energy transfer (LET) radiations in both genders. Many studies showed a pro-
tection factor (PROFAC) > 0.40 (40% avoided) against the occurrence of lung cancer. The
ubiquitous nature of the radiation hormesis response in cellular, animal, and epidemio-
logical studies negates the healthy worker effect as an explanation for radiation hormesis.
Low-dose radiation may stimulate DNA repair/apoptosis and immunity to suppress and
eliminate cigarette-smoke-induced transformed cells in the lung, reducing lung cancer
occurrence in smokers.
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SMOKING AND CANCER
Cigarette smoke is a complex mixture of more than 6000 chemicals
that are separated into a vapor phase and a particulate phase, and numer-
ous carcinogenic compounds have been identified in primary and side-
stream tobacco smoke. Hundreds of chemicals in tobacco smoke, of
which more than 40 are known to cause cancer in humans and/or ani-
mals (Sanders 1996), react covalently with DNA to form adducts or pro-
duce free radicals causing oxidative damage.
Approximately one-third of all cancers in the United States are relat-
ed to tobacco use, including active and passive cigarette smoke exposures
and use of smokeless products (USDHHS 1990). The Surgeon General’s
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annual report on smoking and health for 2004 listed causal relationships
between smoking and cancer in the bladder; cervix; esophagus; kidney;
larynx; lung, oral cavity; pharynx; pancreas and stomach; and for acute
myeloid leukemia, and Hodgkin’s lymphoma (USDHHS 2004). Lung
cancer frequency in the United States is significantly influenced by race,
gender, and lifestyle (ALA 2005), and approximately 20% of cigarette
smokers will develop lung cancer. Lung cancer survival rates are poor,
with only 10% of patients living longer than 1 yr after diagnosis, while
smoking is responsible for over 90% of lung cancer deaths (Sethi 1997).
The lung cancer incidence in Dresden has increased approximately 100-
fold from 0.06% in 1852 until today and is directly linked to cigarette pro-
duction that began in Dresden in 1862 (Deetjen and Falkenbach 1999).
For ex-smokers, the risk of lung cancer is highly dependent upon the
number of cigarettes smoked per day, as well as the duration, and length
of time since stopping smoking (USDHHS 1982). The relative risk (RR)
for lung cancer in heavy smokers living in the United States, France,
Spain, and Germany ranges from 20–46. The RR for lung cancer in
France was 15.6 for current smokers, 9.2 for ex-smokers who stopped
within the previous 10 yr, and 2.9 for ex-smokers who stopped at least 10
yr earlier; similar incidences of lung cancer are also seen in other Western
countries (Sanders 1996; Rossi and Zaider 1997; Kreienbrock et al. 2001;
Barros-Dios et al. 2002; Baysson et al. 2004; Wichmann et al. 2005). 
INTERACTION OF RADIATION AND SMOKING
Over 100 separate studies of radium dial painters; hard rock and ura-
nium miners; radiologists and radiological technicians; nuclear workers;
X-ray technicians; residents with high indoor radon; radium therapy,
thorotrast and ankylosing spondylitis patients; and Hodgkin disease, pedi-
atric cancer; thymus hypertrophy, tinea capitis, metropathia hemorrhagi-
ca, postpartum mastitis, fluoroscopy, peptic ulcer, female breast cancer,
and benign breast disease patients have all failed to demonstrate a signif-
icant excess of lung cancer incidents at a lung dose < 1 Gy in never smok-
ers (Sanders 1996). A meta-analysis of lung cancer risk after exposure to
low-linear energy transfer (LET) radiations indicated that doses < 2 Gy
did not appear to cause lung cancer, “but, in fact, indicate a reduction of
the natural incidence” (Rossi and Zaider 1997).
Among never smokers, no increase in lung cancer has been found in
flight attendants exposed during flight to elevated background radiation
(Blettner et al. 2002); workers in a uranium processing plant (Dupree et
al. 1995); inhabitants of the United States, India, China, or Iran who
experience background radiation levels that are up to 200-fold higher
than the mean global level (Zahi et al. 1982; Nambi and Soman 1987;
NCRP 2001; Ankathil et al. 2005; Ghiassi-Nejad and Mortazavi 2005;
Mortazavi et al. 2006); Japanese A-bomb survivors (Aurengo et al. 2005);
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radiologists and radiological technicians (Doody et al. 1998; Berrington et
al. 2001; Yoshinaga et al. 2003); residents in the Eastern Urals exposed to
radiation from the 1957 buried nuclear waste tank explosion near the
Mayak plutonium production facility (Kostyuchenko and Krestina 1994);
or Mayak facility workers receiving alpha radiation doses < 1 Gy in com-
bination with gamma rays (Tokarskaya et al.1997). Additionally, Cardis et
al. (1995) found that lung cancer was not increased in nuclear industry
workers from the United States, United Kingdom, and Canada. Evacuees
and others living close to the exclusion zone around Chernobyl received
whole-body doses in the range of 0.1 to 0.5 Gy, and average lung doses
were as high as 0.6 Gy due largely to inhalation of radionuclides
(Baverstock and Williams 2002). Furthermore, no evidence of an
increase in the incidence of lung cancer was found in any group associ-
ated with the Chernobyl accident (Chernobyl Forum 2005; Hatch et al.
2005). The lowest dose for which lung cancer was found in non-smoking
U.S. uranium miners was > 100 working-level months (WLM)† (Hornung
and Meinhardt 1987).
Smoking accounts for a large share of deaths attributed to radiation
— primarily lung cancers –– which are much higher in frequency than for
other solid cancers. A heavy smoker may accumulate an alpha-radiation
dose as high as 1 Gy, mostly from 210Po, to bronchial bifurcations (Martell
1975). The interaction of radiation and smoking exhibits a sub-multi-
plicative or multiplicative relationship in the induction of lung cancer
(Martell 1975; Gray et al. 1986; Janerich et al. 1990; Monchaux et al. 1994;
Thomas et al. 1994; Barros-Dios et al. 2002; Gilbert et al. 2003; Pierce et al.
2003; Wang et al. 2005). Cigarette smoking so confounds studies of lung
cancer formation in irradiated populations that it is difficult to deter-
mine if ionizing radiation even exerts a significant effect on lung cancer
formation in smokers with a RR < 1.5–2.0 (Doll 1992; Schull and Weiss
1992), and little is known about the interaction of smoking and radiation
on non-respiratory tract cancers.
Eighty percent of male A-bomb survivors reported that they were
smokers (Pierce et al. 2003); and of approximately 600 lung cancer cases
in Japanese A-bomb survivors, approximately 50 were related to radiation
using the linear no-threshold (LNT) hypothesis (Kopecky et al.1986;
Pierce et al. 1996). An increase in lung cancer in never smokers was not
detected. These few “excess” lung tumors could be mostly explained by
the uncertainty of smoking habits (Little 2002). Providing a risk factor
based upon so few tumors and such uncertainty of smoking habits does
not give much confidence as to their accuracy. Presently, there are no cur-
rent methodologies for low tumor prevalence that can accurately dis-
Smoking and hormesis in radation pulmonary carcinogenesis
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criminate between the different possible causes of cancer (Heidenreich
et al. 2002).
Insufficient data was given in many published papers for others to
evaluate lung cancer risk at low doses. Low-dose and smoking data used
to determine the excess relative risk (ERR) for lung cancer in Mayak
workers was not provided (Kreisheimer et al. 2000; Shilnikova et al. 2003;
Gilbert et al. 2004). Lung cancer mortality estimates for the Semipalatinsk
cohort, downwind from the Kazakhstan weapons test site, did not ade-
quately control for smoking; no data was given for the 20–70 mSv cohort
and data for the 70–249 mSv cohort was combined from several dose
groups (Bauer et al. 2005). A previous Portsmouth Naval Shipyard work-
er-positive ERR value for lung cancer was negated by a later study that
adjusted for smoking, welding fumes, and asbestos exposure (Yiin et al.
2005). Likewise, no data was given for exposures to asbestos or for smok-
ing history in a study of lung cancer in Hanford workers (Wing and
Richardson 2005). Cohorts of nuclear workers in 15 countries were eval-
uated in a meta-analysis of cancer risk estimation, but risk by dose level
was not given for each study. The authors admit that their data may be
confounded by smoking (Cardis et al. 2005).
RADIATION HORMESIS
Hormesis is derived from the Greek word, hormaein, to excite. A cur-
rent hormesis hypothesis states that low-level stress (e.g., via irradiation)
stimulates a system of protective biological processes at the cellular,
molecular, and organismic levels, decreasing cancer incidences and the
incidences of other deleterious health effects below spontaneous levels
(Scott 2006a,b,c) (Figure 1). Broadly based data showing hormesis has
been found independently of chemical or physical agent, or biological
model and endpoint (Calabrese 2005; Calabrese and Baldwin 2003). 
Recent research has led to the formulation of a sound scientific basis
for radiation hormesis (Luckey 1991; Stephens et al. 1991; Calabrese and
Baldwin 2000, 2001; Cohen 2002b; Scott 2005, 2006a,b; Scott et al. 2006).
A biological basis for radiation hormesis has been proposed and relates
to activated DNA repair, apoptosis (self destruction), and stimulation of
the immune system (Scott et al. 2006). Cells carry in their genome a pro-
gram for apoptosis, which limits the accumulation of potentially harmful
cells. Failure to regulate tissue homeostasis can result in cancer develop-
ment (Thompson et al. 1992). Cell regulators, such as growth factors,
cytokines, and hormones, are involved with the activation and repression
of genes associated with apoptosis. Stephens et al. (1991) found that
apoptosis is enhanced by low to moderate doses of ionizing radiation in
normal tissues and tumors; and Scott et al. (2006) notes that high fidelity
DNA repair is also activated above a threshold dose. 
C. L. Sanders and B. R. Scott
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Two forms of apoptosis (normal which is presumed to involve p53,
along with an auxiliary protective apoptosis-mediated [PAM] process that
is considered to be independent of p53) have been incorporated into a
biologically based model of low-dose-induced stochastic radiobiological
effects (Scott 2005, 2006a,b; Scott et al. 2006). Normal apoptosis backs up
the DNA repair pathway by removing severely damaged cells to undergo
repair. The auxiliary PAM process removes mutant, neoplastically trans-
formed, and other genomically unstable cells that arise as a result of mis-
repair (or no repair) of DNA damage (Scott 2005).
The PAM process, along with stimulation of the immune system, lim-
its potential cancer formation when activated by low LET-radiations such
as gamma rays and x-rays (Scott 2005, 2006a,b). Stimulation of the PAM
process by low-dose, low-LET radiation may cause apoptosis of cells trans-
formed by the other agents, including chemical carcinogens in cigarette
smoke. A significant suppression of 20-methylcholanthrene carcinogene-
sis was found in ICR female mice given gamma-irradiation at 1 mGy/h
(Sakai et al. 2003). Mice exposed dermally to 50 cGy beta-irradiation 24 h
prior to treatment with the chemical carcinogen methyl-nitro-nitroso
guanidine reduced papilloma frequency by approximately 5-fold
(Mitchel et al. 1999). Low-dose ionizing radiation may enhance the elim-
ination, by apoptosis, of cigarette-induced transformed pulmonary cells,
thus decreasing lung cancer risk (Scott 2006b). Activated high fidelity
DNA repair by low doses of low-LET radiation is also considered a con-
tributing factor in suppressing the occurrence of stochastic effects of
other carcinogens.






















FIGURE 1. Possible radio-adaptive mechanisms that contribute to PROFAC during cigarette smok-
ing-induced pulmonary carcinogenesis. 
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In his book, Radiation Hormesis, Luckey (1991) describes evidences
of hormesis in workers at nuclear facilities, A-bomb survivors, and many
other groups exposed to low doses of radiation. The hormesis response is
associated with increased lifespan as well as decreased mutations, chro-
mosome aberrations, neoplastic transformations, congenital malforma-
tions, and cancer (Lorenz et al. 1955; Brown et al. 1963; Frigerio et al.
1973; Jaworowski 1995; Spalding et al. 1982; Wei 1997; Caratero et al. 1998;
Kant et al. 2003). 
Relative Risk and the Protection Factor
A novel biological-based hormetic relative risk (HRR) model for can-
cer induction by low-dose, low-dose-rate irradiation has emerged out of
concern about the inappropriateness of the LNT hypothesis (Scott
2006a,b,c). A low-dose form of the HRR model is presented below and is
used to characterize, in a systematic manner, hormetic responses
observed in many irradiated human populations. 
Based on the demonstrated close similarity between the RR dose-
response relationships for radiation-induced neoplastic transformation in
vitro and for cancer induction in humans (Redpath et al. 2001), a novel,
RR model for neoplastic transformation was adapted for application to RR
estimation in irradiated human populations. The model is rather complex
(Scott 2006a,c) in that it involves different thresholds for activating and
inhibiting the hormetic response in different humans. Low doses activate
(stimulate) while moderate and high doses inhibit this response.
For low doses and dose rates that are associated with the hormetic
zone (a low-dose zone with the lower end usually including elevated back-
ground radiation), a system of protective processes (PAM process along
with a stimulated immune system, in addition to activated high-fidelity
DNA repair) are considered to be maximally stimulated (Scott 2005,
2006a,b). For this dose zone, the RR at dose D (absorbed dose of all radi-
ation involved) is given by the following:
RR = 1, for D = 0,
RR = 1 - PROFAC, otherwise. (1)
The protection factor (PROFAC) gives the proportion of cancer cases
(incidence or mortality) that are avoided among those cases that would
otherwise have occurred spontaneously or in the absence of radiation
hormesis. PROFAC, however, relates only to the low-LET component of
the dose. Exposure to uranium ore dust and γ-rays may contribute 25-75%
of the ‘effective’ dose to the lung in uranium mines. Applying this obser-
vation decreases the risk estimates of lung cancer by radon by a factor of
2-3, implicating no effect of radon and/or the presence of a threshold for
C. L. Sanders and B. R. Scott
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lung cancer risk (Duport 2002). Thus, for radon exposures, PROFAC
relates to the gamma-ray component of the radiation dose. High-LET
alpha radiation by itself does not appear to activate the system of protec-
tive processes associated with radiation hormesis (Scott 2005, 2006b).
However, more research on this topic is needed.
Thus, for exposure to low doses and dose rates of low-LET radiation or
combinations of low- and high-LET radiations the dose-response curve is
predicted to drop to a constant value given by 1 - PROFAC rather than
increase as postulated by the widely used LNT hypothesis. However, there
is a dose-rate dependent transition zone (Transition Zone A) where the
individual-specific threshold for activating the protective hormesis process
occurs (Scott 2005, 2006b). Over this zone, the dose-response curve is
expected to progressively decrease below RR = 1 rather than suddenly
drop to 1 - PROFAC. In any case, the lowest point of the dose-response
curve can be quantified based on 1 - PROFAC. Further, this characterization
of RR is expected to apply for most of the hormetic zone. Thus, where data
are available for RR < 1 after a low dose, for low-dose-rate exposures to low
or low plus high-LET radiations PROFAC can be justifiably estimated using:
PROFAC = 1 - RR. (2)
Systematic error is expected to underestimate PROFAC when the
equation is used for moderate and high doses, where a more complicat-
ed equation that depends on dose occurs and where hormesis can be sup-
pressed. For doses in Transition Zone A, systematic error is also expected
to favor underestimation of PROFAC. However, again, for a large portion
of the hormetic zone, RR = 1 - PROFAC is expected to adequately char-
acterize the dose-response relationship (Scott 2006a). The product 100
PROFAC allows representing the cancer cases avoided as a percentage
(%) rather than as a proportion.
Standardized mortality ratios (SMR) can be used as estimates of RR,
allowing PROFAC to be obtained based on SMR data. Odds ratio (OR) <
1 could also serve as an estimate of RR for the hormetic zone. However,
for the unexposed group, irradiated persons should be excluded to the
extent possible. Otherwise, a large systematic error could occur leading
to changing a threshold-type hormetic curve into what appears to be a
LNT curve. We have used both RR and SMR data to estimate PROFAC for
a number irradiated human populations where hormetic effects have
been demonstrated or suspected. 
Values for PROFAC significantly > 0 imply that spontaneous cancers
(possibly fatal) are being avoided that otherwise would have occurred in
the absence of radiation hormesis. It should be kept in mind that what
are considered spontaneous cancers may actually be associated with other
environmentally associated risk factors. However, radiation hormesis
Smoking and hormesis in radation pulmonary carcinogenesis
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would also be expected to protect against stochastic effects caused by
such factors. 
For a population residing in a high natural background radiation
area where a significant component of the radiation dose is due to low-
LET radiation, for each 100,000 spontaneous cancer deaths that would be
expected over a given follow-up period in the absence of radiation
hormesis, each increment of 0.1 in the PROFAC (due to radiation horme-
sis) would be expected to save 10,000 lives. Thus, radiation hormesis is
not a trivial benefit. Since many PROFACs reported later exceed 0.3, this
translates into very large numbers of lives being saved due to radiation
hormesis.
The PROFAC is considered to depend on dose rate, the type of radi-
ation (i.e., radiation quality), and the target organ in the body. For mod-
erate doses, more complicated dose-related terms arise and the RR can-
not be adequately described using a single parameter, i.e., PROFAC.
Thus, Equations 1 and 2 should be applied only to low doses and dose
rates and only where the radiation exposure includes low-LET radiation.
Presently, the same PROFAC is considered to apply to cancer incidence
and cancer mortality (Scott 2006b).
Low-level Background Radiation and Hormesis
There are many epidemiological studies that demonstrate evidence
for radiation hormesis (Luckey 1991), and Table 1 shows such studies for
lung. The 13-yr U.S. Nuclear Shipyard Workers Study on the health
effects of low-dose radiation was carried out by Johns Hopkins
Department of Epidemiology (Matanoski 1991). In the study, a high-dose
cohort of 27,872, low-dose cohort of 10,348, and a control cohort of
32,510 unexposed shipyard workers were examined from 1980–1988.
Mortality from all causes was 24% less in nuclear workers than in non-
nuclear workers. The SMR of 0.85 for all malignant tumors in the high-
dose cohort was significantly less (p < 0.05) than in the control cohort;
the PROFAC for lung cancer was 0.07. 
Wilkinson and colleagues studied the causes of mortality for women
working in 12 U.S. nuclear weapons facilities (Wilkinson et al. 2000). The
study covered a total of 67,976 women who worked at these sites before
1980 and compared mortality data for those who wore radiation exposure
monitoring badges with mortality in those workers who did not wear
badges. A strong radiation hormesis effect was seen in all women in all
facilities for all cancers. The study showed that there were 25 percent
more deaths from all causes and 17 percent more deaths from cancer in
unbadged workers than in those wearing badges. The RR for lung cancer
mortality in unbadged women who were not monitored was 49 percent
higher than in badged workers. Additionally, 10 of the 12 facilities
C. L. Sanders and B. R. Scott
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showed decreased lung cancer frequency with PROFAC values ranging
from 0.05 to 0.47 (Wilkinson et al. 2000).
Both the Shipyard and Wilkinson studies, which had appropriate
internal controls for entrance into employment and medical care once
employed, demonstrated clear evidence of radiation hormesis for lung
cancer.
In a cohort of 45,468 Canadian nuclear power industry workers
(1957–1994) the PROFAC for lung cancer was 0.19 in males and 0.60 in
females (Zablotska et al. 2004). The PROFAC for lung cancers at the UK
Chapelcross nuclear plant was 0.43 (p < 0.0001) based on Scottish rates
and 0.35 when based on rates for England and Wales (McGeoghegan and
Binks 2001). At three UK nuclear facilities, the SMR for lung cancer in
workers with the highest cumulative whole-body dose (400+ mSv) was
0.59 for monitored workers and 0.97 for unmonitored workers
(Carpenter et al., 1998). The PROFAC for lung cancer in United
Kingdom Atomic Energy Authority (UKAEA) radiation workers was 0.11
compared to non-radiation workers (Atkinson et al. 2004). 
Mortality was examined in 176,000 Japanese nuclear industry workers
from 1986–1997. The PROFAC for lung cancer was 0.57 and 0.28 at
cumulative doses of 50–100 mSv and > 100 mSv, respectively (Iwasaki et al.
2003). A strong radiation hormesis effect was observed at doses < 50 mSv
(PROFAC = 0.49) and > 50 mSv (PROFAC = 0.56) for total cancer inci-
dence in Korean nuclear workers (Ahn and Bae 2005). Of the 668 work-
ers who died during 1984–1999, only 21 died of lung cancer, making the
PROFAC for lung cancer 0.34 (Jin et al. 2002). Similarly, the PROFAC for
lung cancer was 0.41 in a study of U.S. workers employed at 15 nuclear
power plants between 1979 and 1997 (Howe et al. 2004).
Nearly 200,000 participants in the National Dose Registry of Canada
from 1951–1988 were examined for cancer mortality. For lung cancer, the
standardized incidence ratio (SIR) was 0.64 in males and 0.79 in females
(Sont et al. 2001). Evidence of radiation hormesis (PROFAC = 0.13 at
0.01–0.49 Sv, PROFAC = 0.18 at 0.5–0.99 Sv, and PROFAC = 0.06 at 1.00
–1.99 Sv) (Howe 1995) was found for lung cancer in fluoroscopy patients
being treated for tuberculosis. Another study found a PROFAC of 0.20 at
a cumulative lung dose of 0.84 Sv (Davis et al. 1989). Interestingly, in both
studies the hormesis effect was similar in men and women (Davis et al.
1989; Howe 1995). The PROFAC for lung cancer in the contralateral lung
at 10 or more years after diagnosis of breast cancer in those receiving frac-
tionated radiotherapy was 0.50 at a lung dose of 1.4 Gy (Luckey 2003).
And Prochazka et al. (2005) found increased lung cancer following radio-
therapy for breast cancer only in smokers (RR = 2.0).
The PROFAC for lung cancer in German male and female aircraft
cabin employees exposed to elevated solar and cosmic radiations was 0.43
(females) and 0.23 (males). In contrast the SMR for aircraft accidents
Smoking and hormesis in radation pulmonary carcinogenesis
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TABLE 1. Epidemiological studies demonstrating radiation hormesis in the lung
PROFAC × 100 (%)
Study (workers/patients) Reference All Cancer Lung Cancer
U.S. shipyard Sponsler and Cameron 2005 16 7
Airline crew Blettner et al. 2002; Band et al. 1996 21–29 23–72
U.S. nuclear Howe et al. 2004 35 41
Canadian nuclear Zablotska et al. 2004 26 19-60
Japanese nuclear Iwasaki et al. 2003 6 28–57
Korean nuclear Jin et al. 2002 21–49 34
UK nuclear Carpenter et al. 1998 27 35-41
UKAEA Atkinson et al. 2004 10 11
Russian nuclear Khokryakov and Romanov 1994 7 35
Canadian dose registry Sont et al. 2001 21 31
U.S. fluoroscopy Howe 1995 — 6–18
U.S. technologists Doody et al. 1998 — 17–39
Japanese technologists Yoshinaga et al. 1999 — 38–55
Indoor radon Cohen 1995 — ~20
Japanese radon spa Mifune 1992 37 45
British radiologists Berrington et al. 2001 29 26–100
U.S. female nuclear Wilkinson et al. 2000 17 47
Breast cancer patients Luckey 2003 — 50
Mayak plutonium Khokhriakov and Romanov 1996 — 47–61
ranged from 48–96 (Blettner et al. 2002). The SIR for lung cancer in
pilots of Air Canada was 0.28, while the SMR for aircraft accidents was
26.6 (Band et al. 1996).
British radiologists who joined UK radiological societies between 1897
and 1979 were divided into four groups depending on when they joined:
1897–1920, 1921–1935, 1936–1954, and 1955–1979. Exposure limits dur-
ing 1936–1954 were 2 mSv d–1 or 500 mSv yr–1, and 50 mSv yr–1 from
1955–1979. SMR comparisons were made with UK male non-radiology
physicians (Table 2). The PROFAC for all cancers was 0.29 in the
1955–1979 cohort, while the PROFAC for lung cancer was 0.26 in the
1936–1954 cohort and 1.0 for the 1955–1979 cohort (6.5 cases were
expected and none observed) (Berrington et al. 2001). The PROFAC for
all cancer for all age-matched men was 0.54. For all cohorts post 1920 the
PROFAC for lung cancer was 0.30 (Berrington et al. 2001). The PROFAC
for lung cancer in Japanese technologists was 0.38 for those who worked
from 1897–1933 and 0.55 for those who worked from 1934–1950
(Yoshinaga et al. 1999). The PROFAC values for lung cancer in U.S. tech-
nologists who worked from 1926–1939, 1940–1949, 1950–1959, 1960–1982
were 0.28, 0.24, 0.17, and 0.39, respectively (Doody et al. 1998).
Recycled steel contaminated with cobalt-60 was used in the construc-
tion of more than 180 buildings in Taiwan that housed 10,000 persons for
a 9-–20-yr period.. The average whole-body dose for these residents was
0.4 Sv given at an average dose-rate of 50 mSv/yr. Of the approximately
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1,100 persons who received cumulative doses of 4 Sv from 1983–2003,only
seven cases of fatal cancer were found. The cancer mortality rate of resi-
dents was 3.5 per 100,000 person-years, while the expected spontaneous
cancer mortality rate was 116 persons per 100,000 person-years, giving
residents a PROFAC 0.97 for fatal cancer. Yet the LNT hypothesis used by
the International Commission on Radiological Protection (ICRP) pre-
dicted 302 cancer deaths in the Taiwan study –– 232 spontaneous and 70
caused by radiation (Chen et al. 2004).
A PROFAC for lung cancer of 0.35 was found at a dose-range of
0.26–1.0 Sv in Russian nuclear radiochemical workers at Mayak
(Khokhryakov and Romanov 1992, 1994). The workers had mean lung
doses that ranged from 1–2 Gy, and nearly all lung cancer cases were
found in smokers. A linear fit for a lung cancer and smoking index has
been employed for Mayak workers (Tokarskaya et al. 1995, 1997; Jacob et
al. 2005). Estimates of radiation-induced lung cancer have been greatly
overestimated when not adjusting for cigarette smoking. A RR = 0.91 for
lung cancer was found in Mayak workers with lung gamma-ray doses > 2
Gy (Tokarskaya et al. 2002). 
A Mayak case-control study of all morphologically verifiable lung can-
cer cases from 1966–1991 among the Mayak nuclear workers found a
threshold of 3.7 kBq or 0.80 Gy for incorporated 239Pu. The incidence of
lung cancer at lung doses < 0.8 Gy was significantly less (p < 0.05) than
control levels (PROFACs of 0.44, 0.41, and 0.17 at average 239Pu body bur-
dens of 0.34 kBq, 1.2 kBq, and 4.2 kBq, respectively) (Tokarskaya et al.
1997). A later analysis indicated a threshold of 1 Gy (20 Sv) and a curvi-
linear relationship between lung cancer and alpha radiation dose
(Tokarskaya et al. 2002). The PROFAC for lung cancer among Mayak
workers from chronic alpha plus gamma irradiation was 0.61 at a lung
dose of 0.1–12 mGy and 0.47 for a dose of 12.1–50 mGy (Khokhriakov
and Romanov 1996). A recent analysis using a more complicated form of
the HRR model, which included an alpha-radiation dose in addition to
the PROFAC, yields an estimate of 0.86 for the PROFAC (Scott 2006b).
Smoking and hormesis in radation pulmonary carcinogenesis
63
TABLE 2. Lung cancer mortality in British radiologists from 1897–1979* 
SMR (COMPARED TO UK
MALE NON-RADIOLOGIST 
PHYSICIANS)
Years Joined Radiological Societies Tolerance or Exposure Limits All Cancers Lung Cancer
1897–1920 > 1 Sv yr–1 1.75 2.46
1921–1935 < 1 Sv yr–1 1.24 1.06
1936–1954 2 mSv day–1 or 500 mSv yr–1 1.12 0.74
1955–1979 50 mSv yr–1 0.71 0
*Berrington et al. 2001
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The results obtained indicated that not only did hormesis-associated pro-
tective processes prevent spontaneous cancer but also reduced the num-
ber of lung cancers associated with alpha irradiation and cigarette smok-
ing by the same factor, i.e., an 86% reduction. Thus, radiation hormesis
appears to not only protect against spontaneous lung cancer but also
against lung cancers associated with cigarette smoking and exposure to
chronic alpha and gamma irradiation.
A study of Rocky Flats Plant employees who worked from 1951–1989
failed to demonstrate a dose-response in lung cancer incidence. Only by
using restrictive regression analyses could an increased lung cancer rate
be shown (Brown et al. 2004). Other studies showed a PROFAC for lung
cancer mortality in plutonium workers at the Rocky Flats Plant of 0.86
(one observed, seven expected) (Tietjen 1987), and Voelz et al. (1983)
found a PROFAC 0.80 for lung cancer in these plutonium workers.
Manhattan Project plutonium workers had a median internal dose of 1.25
Sv and in all causes of death a PROFAC of 0.57 compared to the general
population; their PROFAC for lung cancer was 0.32 (Voelz et al. 1997). 
A cohort of 4402 workers at the Mound Facility were chronically
exposed to 210Po from 1944–1972 but no dose-response trend was
observed. When a 10-yr latency period was considered, the PROFACs for
lung cancer at the two highest dose groups were 0.46 and 0.66 (Wiggs et
al. 1991). UK workers at the Springfields uranium fuel fabrication facility
had a median cumulative dose of 9.3 mSv and a PROFAC of <1 for lung
cancer, while UK 235U enrichment workers at the Capenhurst facility had
a median cumulative dose of 1.7 mSv and a PROFAC of <1
(McGeoghegan and Binks 2000a,b).
RADON
Radon exposure involves both high-LET alpha and low-LET gamma
radiations. The gamma ray component is considered to stimulate hormet-
ic effects (Scott 2005, 2006a,b). The beneficial effects of inhaled radon
and radon-laden water are evident in Russian and European spa hospitals
where hundreds of thousands of patients are annually treated for a vari-
ety of inflammatory, immune, and hormonal disorders at radon concen-
trations up to a 1000 times that of the U.S. Environmental Protection
Agency (USEPA) residential radon limit (Deetjen and Falkenbach 1999;
Mitsunobu et al. 2003; Yamaoka et al. 2005). Protracted low-dose irradia-
tion with radon enhances cell-mediated immunity and reduces pul-
monary metastasis of melanoma in mice (Takahashi and Kojima 2006).
Radon balneology (therapeutic effects of baths) has been shown to be
effective in randomized double-blind studies (Franke et al. 2000).
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†WL, working level; WLM, working-level months; 1 WL = 3700 Bqm–3 = 100 pCiL–1; 1 WLM
= 1 WL for 170 h = 5.1 mSv.
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Bogoljubov (1988) found an optimum therapeutic dose for radon of 2
mSv given over a 2-wk period. Interestingly, no increase in lung cancer
has been found in radon spa never smoking patients or residents living in
nearby high background radiation areas. 
Normal background radiation exposures are mainly in the range of
2.5–4.0 mSv yr –1. However, they can exceed 10 times these values in vari-
ous parts of the world (Wei 1997). More than half (~ 2 mSv yr–1) of the
United States’ natural background radiation is associated with radon
(mostly 222Rn) and its daughter radionuclides. About 250,000 Americans,
living in a handful of Rocky Mountain states where lung cancer rates are
much lower than predicted by the USEPA using the LNT hypothesis,
receive background exposures of ~ 40 mSv yr–1 (ACS 1997; Jagger 1998).
Relative to other states, Colorado has the third lowest lung cancer death
rate in the nation. For the period 1993–1997, the Colorado cancer death
rate per 100,000 population was 48.2 for males and 25.6 for females.
These rates are well below the national averages of 69.4 for males and
34.0 for females. Colorado radon levels are well above the national aver-
age, averaging 7.3 pCi/L. The USEPA estimates the average indoor radon
level nationwide is 1.3 pCi/L (City of Fort Collins 2005). The relative
rates of cancer in most native populations of Iran, India, and China that
are exposed to high levels of background radiation have, in most cases,
appeared to decrease (Wei 1997; NCRP 2001). Residents near Yangjiang
in Guangdong province, China, receive an annual background dose of
6.4 mSv. The PROFAC was 0.19, while the ERR per Sievert for lung can-
cer was -0.68 under the apparently inappropriate LNT assumption (Wei
1997; Wei and Sugahara 2000). Use of the LNT function seems inappro-
priate in that a PROFAC > 0 implicates a hormetic dose-response.
According to the Biological Effects of Ionizing Radiation Report
(BEIR) VI, the estimated annual number of radon-related lung cancers in
never smokers in the United States ranges from 2,100–2,900 (NRC 1999).
The National Research Council (NRC) found that exposure to radon in
underground mines is associated with an increased risk of lung cancer
(NRC 1999). Although a large fraction of uranium miners were smokers
and smoking-related small-cell carcinoma represents the majority of lung
cancer cases in American uranium miners (NRC 1999; Saccomanno et al.
1996), the RR for lung cancer was ~ 25–29 in uranium miners with cumu-
lative exposures of > 1,450 WLM† compared to those exposed to < 80
WLM (Gilliland et al. 2000; Lubin et al. 1995). One Working Level Month
(WLM) corresponds to an exposure to one Working Level (WL) for 170
hours. One WL is equivalent to the potential alpha energy present in 100
pCi L–1 or 3,700 Bqm-3 of 222Rn in equilibrium with its short-lived decay
products. Most cohort studies of uranium miners used the LNT hypothe-
sis to estimate lung cancer risk (Lubin and Boice 1997; NRC 1999). The
ERR per WLM in never smokers was about three times higher than in
Smoking and hormesis in radation pulmonary carcinogenesis
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smokers (Lubin et al. 1995). A study of Australian uranium miners
showed an increased lung cancer risk at exposures > 40 WLM (Woodward
et al. 1991). A case-control study of WISMUT company uranium miners in
Germany did not show a statistically significant increase for the incidence
of lung cancer until cumulative exposures of > 800 WLM (Bruske-
Hohlfeld et al. 2006).
The combined effect of indoor radon and smoking has not been clar-
ified. The ability of indoor radon to cause lung cancer in never smokers
is unclear (Krewski et al. 1999; Neuberger and Gesell 2002; Neuberger
and Field 2003). Nearly all individual epidemiological studies of lung can-
cer from indoor radon fail to demonstrate a clear dose-response rela-
tionship, which is the strongest criteria for inferring causation.
Essentially, all studies of indoor radon fail to find a significant association
with lung cancer in never smokers (Krewski et al. 1999; Neuberger and
Gesell 2002; Darby et al. 2005). No significant risk of lung cancer was
found in never smokers in two large meta-analysis studies of indoor radon
(Lubin and Boice 1997; Darby et al. 2005). Neuberger and Field (2003)
reviewed the role of radon in the IARC (International Agency for
Research on Cancer) database and could not find a single study that
found it to be an occupational risk factor for lung cancer in never smok-
ers. Detailed data on smoking status and dose groupings was not given in
a number of studies (Neuberger and Gesell 2002). 
Radon Exposure and Relative Risk
Several case-control epidemiological studies have investigated the rela-
tionship of radon exposure and lung cancer, presenting risk as ERR using
the LNT hypothesis (Kreuzer et al. 2003); most of the studies show a posi-
tive ERR using the LNT hypothesis. However, some studies showed a neg-
ative ERR (Blot et al. 1990; Letourneau et al. 1994; Kreienbrock et al. 2001).
In a report on indoor radon and lung cancer in France, Baysson et al.
(2004) claimed a small ERR. The data was compatible with a decreasing
risk rather than an increasing risk (Lachet 2005). A well designed case-
control study in Finland over a large range of indoor radon concentra-
tions (50–1277 Bq/m3 or 1.4–34.5 pCi/L) failed to show an increase in
lung cancer in smokers (Auvinen et al. 1996). The Iowa radon lung cancer
study, using ERR estimates, claims a non-significant increase in lung can-
cer in never smokers at 5–19 WLM. However, it does not present data on
the various dose groupings from which the estimate was constructed. But
Field et al. (2000) found there were also significant differences in demo-
graphic characteristics between cases and controls (Field et al. 2000). 
Meta-analyses of case-control studies of lung cancer risk and radon
exposure failed to provide relative risk data for dose-exposure groups in
each study, giving only the excess odds ratio at 100 Bq/m3 obtained by
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regression using the LNT hypothesis (Krewski et al. 1999, 2005; Darby et
al. 2005). A meta-analysis of eight case-control studies of indoor radon
and lung cancer showed significant differences between the studies in
exposure-response relationships (Lubin and Boice 1997), and five of the
studies showed evidence of hormesis (Kauffman 2003). In the Shenyang,
China, study, a PROFAC of 0.25 was found at 200–249 Bq/m3 and no risk
of lung cancer in never smokers was found at any radon dose (Lubin et
al. 2004).
Cohen’s study encompassed about 300,000 radon measurements in
1,601 counties of the United States, representing about 90% of the resi-
dents living there (Cohen 1995). The trend of county lung cancer mor-
tality was strikingly negative even after adjusting for smoking and many
other socioeconomic factors. Using ecologic epidemiological studies,
Cohen found a consistent, strong inverse relationship between indoor
radon and lung cancer in non-smoking males and females as well as for
smoking males and females (Cohen 1987, 1990, 1993, 1995). For lung
cancer in males the slope was -7.3 %/pCiL–1 for 1970–1979 data and -7.7
%/pCiL–1 for the 1979–1994 data (Cohen 2000b). Equally strong nega-
tive correlations with radon exposure were also found for oral and laryn-
geal cancers associated with smoking (Puskin 2003). Cohen’s data points
have very small error bars which are given for small increments of dose.
Cohen later evaluated over 500 confounding issues using a wide variety of
tests and models (Cohen 1995, 2000). Testing of a BEIR-VI proposal
(NRC 1999) failed to explain the negative association of lung cancer with
radon dose (Cohen 1999). Nothing explained the large negative correla-
tion of lung cancer with increasing radon exposure. A lower absolute oxy-
gen concentration in inspired air at higher altitudes was postulated as the
cause of fewer lung cancers (Van Pelt 2003). An increase in red blood cell
production stimulated by renal release of erythropoietin in response to
reduced oxygen levels at high altitudes would normalize tissue oxygen
levels to those at sea level (Huff et al. 1951). At higher lung doses the radi-
ation hormesis effect disappears and the lung cancer risk reaches the
expected spontaneous incidence. 
Numerous reports have shown a negative relationship between envi-
ronmental radon levels and lung cancer rates and a threshold (Bowie and
Bowie 1991; Neuberger 1992; Wang et al. 2002; Ghiassi-Nejad and
Mortazavi 2005; Mortazavi et al. 2006). A case-control study in Finland
gave results on lung cancer similar to that of Cohen (Auvenin et al. 1996).
Haynes evaluated 55 counties in England and Wales and also found a sta-
tistically significant negative association between radon concentration
and lung cancer (Haynes 1988). Furthermore, a Swedish study suggested
a PROFAC of 0.10 in smokers exposed to indoor radon, yet no increased
lung cancer was seen in nonsmokers at doses >10.8 pCi/l (Pershagen et
al. 1994). The PROFAC for lung cancer in female non-smokers in four
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counties of Saxony in East Germany was 0.40. The average indoor radon
levels exceeded the country average by 3- to 10-fold (Arndt 1992). Overall
RR of lung cancer in females in the Free State of Saxony was 0.98 for
radon levels of < 100 500 Bq/m3 (Kaletsch et al. 1999). A fewer number of
lung cancers than expected were found in the northeast Hungarian vil-
lage of Matraderecske, which has a radon level range of 110–165 Bq/m3
(Toth et al. 1998). In Western Germany the PROFAC was 0.19 at > 140
Bq/m3 with an ERR of -0.12, but the ERR was -0.02 when adjusted for
smoking and asbestos (Kreienbrock et al. 2001). The RR of lung cancer in
a radon spa area of Japan was significantly less than in controls with PRO-
FAC values of 0.45; for all cancers the PROFAC was 0.33 (Little 2002).
DISCUSSION
Socioeconomic status, diet and exercise may play an important role in
lung cancer risk (Sanders 1996; Mattson 2005; Mao et a 2001l; Faggiano
et al 1997). Cancer incidence varies widely among countries of the world
with inter- and intra-country incidences of site-specific cancers varying by
over 100-fold, correlating with a wide range of dietary and lifestyle vari-
ables (Singletary 2000; Parkin et al. 2003). At least 25 classes of phyto-
chemicals have been shown to exert significant anticarcinogenic activity
in animals and humans (Moon and Mehta 1989; Roe 1994; Sanders 1996;
Hecht 1999; Feinberg et al. 2002). Numerous studies have shown that
exercise and dietary caloric restriction decrease tumorigenesis and
enhance antioxidant compounds and immune defenses (Kohl et al. 1988;
Roe 1990; Paffenbarger et al. 1992; Sanders 1996; Masoro 2005).
Environmental exposure to side-stream cigarette smoke is a major
indoor air pollutant that poses a significant health hazard to never smok-
ers (Wu-Williams et al. 1990). Lung cancer deaths from passive cigarette
smoke exposure account for approximately a quarter of lung cancers
seen in never smokers (Janerich et al. 1990). The RR of lung cancer in
married never smokers varies up to 3.4, increasing with increased spousal
cigarette consumption (USDHHS 1986; Fontham et al. 1994). 
Cigarette smoke is in itself a complex mixture of chemicals that syner-
gistically interacts with ethanol to induce oral/pharyngeal cancers (Blot
1992) and with asbestos to induce lung cancer (Hammond et al. 1979). RR
values for lung cancer in asbestos workers, smokers, and asbestos workers
who smoked were 5.2, 11, and 54, respectively (Hammond et al. 1979).
Lung cancer in humans is also associated with exposures to a variety of
other chemical agents (Sanders 1986; Williams and Sandler 2001). The
RR for lung cancer for residents in urban areas of high air pollution is
about 1.5 times greater than for people living in rural areas (Lave and
Seskin 1970; Jedrychowski et al. 1990). The BEIR VII report (NRC 2005)
and radioprotection agencies have not considered the role of many posi-
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tive and negative confounding factors in determining risk estimates of
lung cancer from exposure to ionizing radiation.
The cancer burden from tobacco use is enormous, confounding the
often much smaller lung cancer risks associated with ionizing radiation.
Useful assessments of radiation risk require accurate estimation of active
and passive cigarette smoking exposures. The synergistic interaction of
smoking and high-level radiation makes cancer estimation from high-
level radiation even more difficult (Tokarskaya et al. 2002). Because of
this synergism, passive cigarette smoke exposure in never smokers may
also enhance the risk of radiation effects in the lung. Studies in never
smokers to delineate the effects of passive smoke exposure and radiation
need to be carried out; but there is no evidence for radiation risk of lung
cancer in never smokers at doses < 1–2 Gy. If the interaction between radi-
ation and smoking is more than additive, then the radiation-related risk
of lung cancer would be greater in smokers than in never smokers.
Nuclear facilities, in addition to prohibiting smoking at the work site
should also educate their workers on the synergistic effects of smoking
and radiation.
In their review of the literature, Rossi and Zaider (1997) said: “A crit-
ical review of the literature leads to the conclusion that at the radiation
doses generally of concern in radiation protection (< 2 Gy), protracted
exposure to low linear-energy transfer (LET) radiation (x- or gamma
rays) does not appear to cause lung cancer”. Our conclusions are similar
and extended to < 1 Gy doses in the lung from protracted high LET alpha
irradiation from inhaled radon and 239Pu in combination with protracted
low-LET gamma rays. The low-LET radiation component (e.g., gamma
rays as is associated with radon and gamma-ray exposure of Mayak work-
ers) is thought to trigger the hormetic response and protect against sto-
chastic effects of the alpha radiation dose (Scott 2005, 2006b).
The BEIR VI committee estimated that 10–15% of the annual
160,000 lung cancer deaths in the United States may be attributed to
indoor radon, with an uncertainty of 3,300–32,000 deaths (Krewski et al
1999; NRC 1999). The committee used lung cancer data from 11 major
studies of underground miners, who are the most heavily exposed to
radon, to estimate the risk of lung cancer by radon in residences (NRC
1999). The mean cumulative exposure among miners was about 30-fold
higher than that found in an average home. The BEIR VI committee
felt that it is especially difficult to estimate radon risks for never smok-
ers in homes using high-dose data from uranium miners; “Most of the
radon-related deaths among smokers would have not occurred if the
victims had not smoked” (NRC 1999). The committee also felt that the
assumption of linearity of risk down to the lowest exposures could not
be validated against observational data due to the possible presence of
a threshold (NRC 1999). 
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The healthy worker effect (HWE) is the name given to a common
observation of employee cohorts that show a reduced mortality from all
causes and/or cancer than those in the general population. The HWE has
been attributed to pre-employment medical screening examinations, bet-
ter working and socioeconomic conditions, and superior medical care for
nuclear facility personnel. The HWE is negated by epidemiological studies
of cancer mortality rates in exposed and unexposed workers in the same
plant (Table 3) (Luckey 1991, 2003; Mortazavi and Ikushima 2006). The
radiation workers were compared in several studies with non-radiation
workers in the same plant, facility, or environment in order to decrease the
biases associated with the HWE. The HWE is usually weaker for mortality
from all cancers than for all causes of death (Baillargeon 2001). No reduc-
tion in mortality from all cancers was found in men who received annual
medical physicals compared to men who did not (Friedman et al. 1986;
Franks et al. 1996). The HWE does not explain radiation hormesis respons-
es found in epidemiological studies that do not include workers.
Epidemiological studies that compare exposed and unexposed cohorts in
the same company or workplace, where medical procedures for employ-
ment and employee health are similar, should best delineate the HWE
from hormesis (Luckey 1991). The large size of the Nuclear Shipyard
Worker Study and Wilkerson multi-facility studies for exposed and control
cohorts provided powerful, statistically significant evidence for radiation
hormesis (Matanoski 1991; Wilkinson et al. 2000). The PROFAC of 0.29 for
all cancers in British radiologists compared to all other physicians’ special-
ties also excludes the HWE (Berrington et al. 2001; Cameron 2002). These
studies, which had appropriate internal controls for entrance into employ-
ment and medical care once employed, demonstrated clear evidence of
radiation hormesis and not a HWE. The rather ubiquitous nature of HWE-
like radiation hormesis responses in cellular, animal, and epidemiological
studies would also negate the HWE as an explanation for the radiation
hormesis phenomenon in human population studies (Sanders 2006).
With the LNT hypothesis, any dose of radiation is expected to
increase the risk of lung cancer. In using the LNT hypothesis, BEIR VII,
ICRP, USEPA, and National Council on Radiation Protection and
Measurements (NCRP) ignore the possible presence of any threshold.
Although admitting that simple extrapolation from high doses may not
be justified, they feel that it is scientifically justified to do so (Sanders
2006). In stark contrast, the 2005 French Academy of Sciences (Paris)
and the National Academy of Medicine report (Aurengo et al. 2005) con-
cluded that the LNT hypothesis should not be used for low-LET doses <
100 mGy and especially not for doses < 10 mGy for assessing carcinogenic
risks (Tubiana and Aurengo 2005). The French Academies found abun-
dant evidence for radiation hormesis and believed that this data should
be implemented in making radiation protection guidelines (Aurengo et
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al. 2005). “No one has been identifiably injured by radiation while work-
ing within the first numerical standards set first by the NCRP and then the
ICRP in 1934” (Taylor 1980). The 1934 ICRP standard was about 500 mSv
yr–1 (Cameron 2002).
The LNT hypothesis is widely used for estimating cancer risk, even
though it has not been validated by scientific study and is not consistent
with radiobiological data (Calabrese and Baldwin 2000; Tubiana 2003;
Aurengo et al. 2005). Comparatively little thought has been given by the
BEIR committees and the ICRP to hormesis associated with the radiation
adaptive response and thresholds at low doses and low dose-rates
(Feinendegen et al. 1988; Shadley and Wiencke 1989; NRC 1999, 2005;
ICRP 2004), yet the BEIR VII report and the ICRP continue to support
the LNT hypothesis (ICRP 2004). Because the LNT hypothesis is very well
established and because many strong radiation protection organizations
are in place, scientists and government officials are very reluctant to seri-
ously consider the implications of the radiation hormesis phenomenon,
which has obvious important health implications (Chen et al. 2004). 
The current biased practice by some who report epidemiological
results is misleading. Meta-analyses or individual epidemiological publi-
cations should provide the cancer risks for all dose categories, including
the lowest doses for each study, and not just a single ERR estimate of can-
cer obtained by the LNT hypothesis. The practice of grouping several
low-dose categories into one dose group to remove evidence of radiation
hormesis should be abandoned. Estimates of excess lung cancer risk at
exposures less than threshold values (such as < 800 WLM in German min-
ers (Bruske-Hohlfeld et al. 2006) are not credible. The LNT hypothesis
should clearly not be used when not appropriate in order to best present
the true dose-response relationship of epidemiological data.
Cells carry in their genome a program for self-destruction called
apoptosis. Apoptosis limits the accumulation of potentially harmful cells.
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TABLE 3. Epidemiological studies with internal controls that negate the HWE* 
PROFAC × 100 
Worker Comparison Reference Lung Cancer (%)
Badged/unbadged U.S. DOE female workers Wilkinson et al. 2000 49
Radiologists/physicians, UK Berrington et al. 2001 26–100
High-dose/control shipyard workers Sponsler and Cameron 2005 7
Monitored/unmonitored UK nuclear workers Carpenter et al. 1998 39
Radiation/non-radiation UKAEA nuclear workers Atkinson et al. 2004 11
Radiation/non-radiation UK nuclear workers McGeoghegan and Binks 
2000a,b; 2001 3–43
*In each study, radiation-exposed cohorts were compared with non-radiation cohorts in the same
workplace or environment to reduce the biases resulting in the HWE.
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Failure to regulate tissue homeostasis can result in cancer development
(Thompson et al. 1992). Cell regulators, such as growth factors, cytokines,
and hormones, are involved with the activation and repression of genes
associated with apoptosis. Apoptosis is enhanced by low to moderate
doses of ionizing radiation in normal tissues and tumors (Stephens et al.
1991). A low-dose PAM process, limiting potential cancer formation, may
be activated by low-dose, low-LET gamma or x-radiations (Scott
2006a,b,c). Low-dose radiation may stimulate apoptosis of cells trans-
formed by chemical carcinogens (Mitchel et al. 1999; Sakai et al. 2003).
Furthermore, low dose ionizing radiation may enhance the elimination
by apoptosis of cigarette-smoke-induced transformed pulmonary cells,
thus decreasing lung cancer risk (Scott 2006b).
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